Skip to main content

BioDiscovery Licenses GeneSight Software to TMRI

NEW YORK, Aug. 28 – Software developer BioDiscovery said Tuesday that it had granted a site license for its GeneSight software to the Torrey Mesa Research Institute.

GeneSight is designed to allow researchers to analyze gene expression data, combining various statistical tools and visualization capabilities. 

"Our microarray facility produces a vast amount of expression data daily, and hosts one of the largest expression databases in agricultural genomics. We need a comprehensive statistical analysis tool that is easy to use and platform independent for our large-scale data analysis projects," Tong Zhu, head of TMRI’s microarray group, said in a statement. 

TMRI of San Diego is a wholly owned subsidiary of Syngenta, an agribusiness.

In addition to GeneSight, BioDiscovery of Marina Del Rey, Calif., also sells ImaGene, a microarray image processing and analysis tool for microarrays, and CloneTracker, a data management program used for microarray fabrication and production.

BioDiscovery did not disclose the financial terms for the site license.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.